The Global Fund estimates that the number of lives saved by programs to which the Fund contributes now stands at 20 million, and will reach 22 million by the end of 2016.
Programs supported by the Global Fund have saved 17 million lives up to the end of 2014, according to the Results Report 2015 released by the Fund on 21 September. The Fund says that it is on track to reach 22 million lives saved by December 2016, the end of the current replenishment period (see graphic).
The incentive funding stream should be eliminated and the money reallocated to countries that need it the most to save lives. This was a central recommendation of the Technical Review Panel Report on Windows 1 and 2 of the new funding model. The first two windows were in May and June of 2014.
The people involved in the Global Fund, and in global health generally, “are at an historic moment when the confluence of scientific advancement, epidemiological intelligence and experience from more than a decade of implementation come together to offer the opportunity to end three plagues as public health threats.”
The Foreign Ministry of France is undertaking an evaluation of the French “contribution” to the Global Fund. France wants to assess the extent to which Global Fund grants promote France’s development objectives and priorities. The evaluation will also assess the challenges faced by the Global Fund in introducing its new funding model.
One of the components of the Global Fund’s evaluation strategy is a system of country reviews conducted with partner organisations. The reviews will assess (1) disease outcomes and impact; (2) the contribution of the Global Fund to these outcomes and impacts; and (3) what factors helped to bring about the changes in outcomes and impact. The last item is referred to by researchers as “causation.”
From now on, annual disbursement decisions and semi-annual reporting will be adopted for all Global Fund grants. The only exception will be for grants whose risk profile requires shorter disbursement decisions or more frequent reporting.
These are part of the changes introduced in February 2013 as part of the Global Fund’s Better Grants for Improved Impact Project.
The Global Fund Board has approved Phase 2 funding for a Round 9 HIV grant in Bosnia and Hercegovina in the amount of $13.5 million. The principal recipient (PR) for the grant is the United Nations Development Programme (UNDP). UNDP is also PR for another HIV grant, which has been essentially completed, and for a TB grant in Bosnia and Hercegovina.
Aidspan has published a paper critiquing the way in which the Global Fund quantifies lives saved through programmes that it supports. The paper was prepared by Dr David McCoy, a public health physician and senior clinical lecturer at Queen Mary University London, and Nele Jensen, a physician.